Search

Start Over Journal or Parent Publication Title Clinical Journal of the American Society of Nephrology

  • Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease

    Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease
    Authors:Djalila Mekahli, KU LeuvenLisa M. Guay-Woodford, Children's National Research InstituteMelissa A. Cadnapaphornchai, Rocky Mountain Hospital for ChildrenLarry A. Greenbaum, Emory UniversityMieczyslaw Litwin, Children's Memorial Health InstituteTomas Seeman, Charles University and Moto University HospitalAnn Dandurand, Cerevel TherapeuticsLily Shi, Otsuka Pharmaceutical Development and CommercializationKimberly Sikes, Otsuka Pharmaceutical Development and CommercializationSusan E. Shoaf, Otsuka Pharmaceutical Development and CommercializationFranz Schaefer, University Children's Hospital Heidelberg
    Date:2022
    Publisher:Wolters Kluwer Health, Inc.
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Impact of a Patient Education Program on Disparities in Kidney Transplant Evaluation

    Impact of a Patient Education Program on Disparities in Kidney Transplant Evaluation
    Authors:Rachel Patzer, Emory UniversityJennie P. Perryman, Emory UniversityStephen Pastan, Emory UniversitySandra Amaral, Childrens Hospital of PhiladelphiaJulie Gazmararian, Emory UniversityMitch Klein, Emory UniversityNancy Kutner, Emory UniversityWilliam M. McClellan, Emory University
    Date:2012
    Publisher:American Society of Nephrology
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • Prospects for mTOR Inhibitor Use in Patients with Polycystic Kidney Disease and Hamartomatous Diseases

    Prospects for mTOR Inhibitor Use in Patients with Polycystic Kidney Disease and Hamartomatous Diseases
    Authors:Vincente E. Torres, Mayo Clinic College of MedicineAlessandra Boletta, San Raffaele Scientific InstituteArlene Chapman, Emory UniversityVincent Gattone, Indiana University School of MedicineYork Pei, Toronto General HospitalQi Qian, Mayo Clinic College of MedicineDarren P. Wallace, University of Kansas Medical CenterThomas Weimbs, University of California Santa BarbaraRudolf P. Wuthrich, University Hospital Zurich
    Date:2010
    Publisher:American Society of Nephrology
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • Renal Replacement Therapy in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation

    Renal Replacement Therapy in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation
    Authors:David J. Askenazi, University of Alabama BirminghamDavid T. Selewski, University of MichiganMatthew Paden, Emory UniversityDavid S. Cooper, Cincinnati Children’s Hospital Medical CenterBrian C. Bridges, Vanderbilt UniversityMichael Zappitelli, Montreal Children’s HospitalGeoffrey M. Fleming, Vanderbilt University
    Date:2012
    Publisher:American Society of Nephrology
    Publication Version:Author Accepted Manuscript (After Peer Review)